Hidden gut infections may sabotage TB recovery, study suggests
NCT ID NCT05048485
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study looked at 141 people being treated for tuberculosis (TB) to see if intestinal parasites or poor nutrition made their recovery harder. Researchers checked stool samples for parasites and measured weight gain and treatment success. Some participants received nutritional supplements for 6 months. The goal was to understand how these factors affect TB outcomes, not to test a new drug.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this research could point to ways to improve TB treatment outcomes by addressing parasite infections and malnutrition.
- What could go wrong
- This is an observational study, not a treatment trial. It cannot prove cause and effect, and results may not apply to all TB patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
141 people
The number who actually took part.
- Started
-
Apr 2022
- Finished
-
Jul 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
The study population is newly diagnosed smear-positive (\>/=1+ AFB) pulmonary TB patients living in Puducherry and Tamil Nadu.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Sputum Ziehl-Neelsen stain positive for AFB (≥1+) * Culture or Xpert positive for Mtb; those who are smear+ but ultimately Xpert or culture negative, will be included until their culture results return at which time they will retrospectively be removed from the study. * No history of TB treatment (i.e., no history of partial or complete treatment for a previous TB episode) * Has at least 1 household contact with whom they have shared a house with during the previous one month * Agrees to have household contact notified about study Exclusion Criteria: * Household contact ineligible for TB LION study * Pregnant at enrollment * Previously diagnosed with diabetes or hemoglobin A1c\>6.5% on testing * No Xpert or culture confirmation and unable to provide sputum sample * Known multidrug-resistant tuberculosis (MDR) or extensively drug resistant (XDR) TB case at recruitment or found at time of enrollment * BMI \<14 kg/m2 * Lower extremity edema/kwashiorkor * Reported neuropathy in lower extremities (may result from thiamine deficiency)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Helminthiasis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Boston Medical Center
Boston, Massachusetts, 02118, United States
-
Jawaharlal Institute of Postgraduate Medical Education and Research
Puducherry, 605006, India
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a 4-Month drug cocktail cure TB as well as 6 months?
- Can IV nutrition at an outpatient clinic help malnourished surgery patients?
- Searching for biomarkers to combat malnutrition
- Can a 4-Drug combo cut TB treatment time in half?
- One diet plan to fight two forms of malnutrition in kids?
- Could a simple ultrasound predict ventilator success in elderly COPD patients?